Timeline: Current late-stage trials are expected to last into 2027. Related stories Novo Nordisk is touting a stronger alternative to Ozempic that may be easier to produce at scale Why it's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback